Publications

1. Gabriel CJ, Gupta TA, Sánchez-Fuentes A, Zeidler Z, Wilke SA, DeNardo LA. Transformations in prefrontal ensemble activity underlying rapid threat avoidance learning.. Current biology : CB, 2025.
2. Gongwer MW, Qi A, Enos AS, Rueda SA, Klune CB, Shari M, Kashay AQ, Williams OH, Hacking A, Riley JP, Wilke GA, Yang Y, Lu H, Leuchter AF, DeNardo LA, Wilke SA. A cell type-specific mechanism driving the rapid antidepressant effects of transcranial magnetic stimulation.. bioRxiv : the preprint server for biology, 2025.
3. Gongwer MW, Etienne F, Moca EN, Chappell MS, Blagburn-Blanco SV, Riley JP, Enos AS, Haratian M, Qi A, Rojo R, Wilke SA, Pridans C, DeNardo LA, De Biase LM. Microglia regulate nucleus accumbens synaptic development and circuit function underlying threat avoidance behaviors.. Research square, 2025.
4. Gongwer MW, Etienne F, Moca EN, Chappell MS, Blagburn-Blanco SV, Riley JP, Enos AS, Haratian M, Qi A, Rojo R, Wilke SA, Pridans C, DeNardo LA, De Biase LM. Microglia regulate nucleus accumbens synaptic development and circuit function underlying threat avoidance behaviors.. bioRxiv : the preprint server for biology, 2025.
5. Zeidler Z, Gomez MF, Gupta TA, Shari M, Wilke SA, DeNardo LA. Prefrontal dopamine activity is critical for rapid threat avoidance learning.. bioRxiv : the preprint server for biology, 2025.
6. Leuchter MK, Citrenbaum C, Wilson AC, Tibbe TD, Jackson NJ, Krantz DE, Wilke SA, Corlier J, Strouse TB, Hoftman GD, Tadayonnejad R, Koek RJ, Slan AR, Ginder ND, Distler MG, Artin H, Lee JH, Adelekun AE, Einstein EH, Oughli HA, Leuchter AF. The effect of older age on outcomes of rTMS treatment for treatment-resistant depression.. International psychogeriatrics, 2024.
7. Tadayonnejad R, Corlier J, Valles TE, Citrenbaum C, Matthews C, Einstein E, Wilke SA, Slan A, Distler MG, Hoftman G, Adelekun AE, Oughli HA, Leuchter MK, Artin H, Koek RJ, Ginder ND, Krantz D, Strouse T, Leuchter AF. Safety and efficacy of targeting the supplementary motor area with double-cone deep transcranial magnetic stimulation vs figure-eight coil in treatment of obsessive-compulsive disorder with comorbid major depressive disorder.. Journal of psychiatric research, 2024.
8. Gabriel CJ, Gupta T, Sanchez-Fuentes A, Zeidler Z, Wilke SA, DeNardo LA. Transformations in prefrontal ensemble activity underlying rapid threat avoidance learning.. bioRxiv : the preprint server for biology, 2024.
9. Slan AR, Citrenbaum C, Corlier J, Ngo D, Vince-Cruz N, Jackson NJ, Valles TE, Wilke SA, Hoftman GD, Koek RJ, Leuchter MK, Krantz DE, Strouse TB, Tadayonnejad R, Ginder ND, Distler MG, Lee JH, Adelekun AE, Einstein EH, Oughli HA, Leuchter AF. The role of sex and age in the differential efficacy of 10 Hz and intermittent theta-burst (iTBS) repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD).. Journal of affective disorders, 2024.
10. Leuchter MK, Citrenbaum C, Wilson AC, Tibbe TD, Jackson NJ, Krantz DE, Wilke SA, Corlier J, Strouse TB, Hoftman GD, Tadayonnejad R, Koek RJ, Slan AR, Ginder ND, Distler MG, Artin H, Lee JH, Adelekun AE, Einstein EH, Oughli HA, Leuchter AF. The effect of older age on outcomes of rTMS treatment for treatment-resistant depression.. International psychogeriatrics, 2024.
11. Leuchter MK, Citrenbaum C, Wilson AC, Tibbe TD, Jackson NJ, Krantz DE, Wilke SA, Corlier J, Strouse TB, Hoftman GD, Tadayonnejad R, Koek RJ, Slan AR, Ginder ND, Distler MG, Artin H, Lee JH, Adelekun AE, Leuchter AF. A comparison of self- and observer-rated scales for detecting clinical improvement during repetitive transcranial stimulation (rTMS) treatment of depression.. Psychiatry research, 2023.
12. Einstein EH, Corlier J, Matthews C, Ngo D, Leuchter MK, Citrenbaum C, Vince-Cruz N, Ramesh B, Slan A, Wilke SA, Ginder N, Strouse T, Leuchter AF. Bilateral Cerebellar Repetitive Transcranial Magnetic Stimulation for Chronic Ataxia After Hemorrhagic Stroke: a Case Report.. Cerebellum (London, England), 2023.
13. Citrenbaum C, Corlier J, Ngo D, Vince-Cruz N, Wilson A, Wilke SA, Krantz D, Tadayonnejad R, Ginder N, Levitt J, Lee JH, Leuchter MK, Strouse TB, Corse A, Vyas P, Leuchter AF. Pretreatment pupillary reactivity is associated with differential early response to 10 Hz and intermittent theta-burst repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD).. Brain stimulation, 2023.
14. Tadayonnejad R, Citrenbaum C, Ngo TDP, Corlier J, Wilke SA, Slan A, Distler MG, Hoftman G, Adelekun AE, Leuchter MK, Koek RJ, Ginder ND, Krantz D, Artin H, Strouse T, Bari AA, Leuchter AF. Right lateral orbitofrontal cortex inhibitory transcranial magnetic stimulation for treatment of refractory mood and depression.. Brain stimulation, 2023.
15. Citrenbaum C, Corlier J, Ngo D, Vince-Cruz N, Wilson A, Wilke S, Krantz D, Tadayonnejad R, Ginder N, Levitt J, Lee JH, Strouse T, Corse A, Vyas P, Leuchter AF. Pretreatment pupillary reactivity is associated with outcome of Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD).. Journal of affective disorders, 2023.
16. Tadayonnejad R, Wilson AC, Chu SA, Corlier J, Citrenbaum C, Ngo TDP, Hovhannisyan E, Ginder ND, Levitt JG, Wilke SA, Krantz D, Bari AA, Leuchter AF. Use of right orbitofrontal repetitive transcranial magnetic stimulation (rTMS) augmentation for treatment-refractory obsessive-compulsive disorder with comorbid major depressive disorder.. Psychiatry research, 2022.
17. Gabriel CJ, Zeidler Z, Jin B, Guo C, Goodpaster CM, Kashay AQ, Wu A, Delaney M, Cheung J, DiFazio LE, Sharpe MJ, Aharoni D, Wilke SA, DeNardo LA. BehaviorDEPOT is a simple, flexible tool for automated behavioral detection based on markerless pose tracking.. eLife, 2022.
18. Marder KG, Cho J, Chincanchan R, Wilson AC, Corlier J, Krantz DE, Ginder ND, Lee JC, Wilke SA, Tadayonnejad R, Levitt J, Ishiyama A, Leuchter MK, Leuchter AF. Sequential Prefrontal and Temporoparietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Tinnitus With and Without Comorbid Depression: A Case Series and Systematic Review.. Frontiers in neurology, 2022.
19. Wilke SA, Johnson CL, Corlier J, Marder KG, Wilson AC, Pleman CM, Leuchter AF. Psychostimulant use and clinical outcome of repetitive transcranial magnetic stimulation treatment of major depressive disorder.. Depression and anxiety, 2022.
20. Leuchter MK, Rosenberg BM, Schapira G, Wong NR, Leuchter AF, McGlade AL, Krantz DE, Ginder ND, Lee JC, Wilke SA, Tadayonnejad R, Levitt J, Marder KG, Craske MG, Iacoboni M. Treatment of Spider Phobia Using Repeated Exposures and Adjunctive Repetitive Transcranial Magnetic Stimulation: A Proof-of-Concept Study.. Frontiers in psychiatry, 2022.
21. Mirman AM, Corlier J, Wilson AC, Tadayonnejad R, Marder KG, Pleman CM, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Ojha R, Daskalakis ZJ, Leuchter AF, Lee JC. Absence of early mood improvement as a robust predictor of rTMS nonresponse in major depressive disorder.. Depression and anxiety, 2022.
22. Wilke SA, Lavi K, Byeon S, Donohue KC, Sohal VS. Convergence of Clinically Relevant Manipulations on Dopamine-Regulated Prefrontal Activity Underlying Stress Coping Responses.. Biological psychiatry, 2021.
23. Lee JC, Corlier J, Wilson AC, Tadayonnejad R, Marder KG, Ngo D, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Leuchter AF. Subthreshold stimulation intensity is associated with greater clinical efficacy of intermittent theta-burst stimulation priming for Major Depressive Disorder.. Brain stimulation, 2021.
24. Corlier J, Tadayonnejad R, Wilson AC, Lee JC, Marder KG, Ginder ND, Wilke SA, Levitt J, Krantz D, Leuchter AF. Repetitive transcranial magnetic stimulation treatment of major depressive disorder and comorbid chronic pain: response rates and neurophysiologic biomarkers.. Psychological medicine, 2021.
25. Tadayonnejad R, Wilson AC, Corlier J, Lee JC, Ginder ND, Levitt JG, Wilke SA, Marder KG, Krantz D, Bari AA, Feusner JD, Pouratian N, Leuchter AF. Sequential multi-locus transcranial magnetic stimulation for treatment of obsessive-compulsive disorder with comorbid major depression: A case series.. Brain stimulation, 2020.
26. Lee JC, Wilson AC, Corlier J, Tadayonnejad R, Marder KG, Pleman CM, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Leuchter AF. Strategies for augmentation of high-frequency left-sided repetitive transcranial magnetic stimulation treatment of major depressive disorder.. Journal of affective disorders, 2020.
27. Lee AT, Cunniff MM, See JZ, Wilke SA, Luongo FJ, Ellwood IT, Ponnavolu S, Sohal VS. VIP Interneurons Contribute to Avoidance Behavior by Regulating Information Flow across Hippocampal-Prefrontal Networks.. Neuron, 2019.
28. Martin EA, Muralidhar S, Wang Z, Cervantes DC, Basu R, Taylor MR, Hunter J, Cutforth T, Wilke SA, Ghosh A, Williams ME. Correction: The intellectual disability gene Kirrel3 regulates target-specific mossy fiber synapse development in the hippocampus.. eLife, 2016.
29. Martin EA, Muralidhar S, Wang Z, Cervantes DC, Basu R, Taylor MR, Hunter J, Cutforth T, Wilke SA, Ghosh A, Williams ME. The intellectual disability gene Kirrel3 regulates target-specific mossy fiber synapse development in the hippocampus.. eLife, 2015.
30. Besterman AD, Wilke SA, Mulligan TE, Allison SC, Hagerman R, Seritan AL, Bourgeois JA. Towards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation Carriers.. Future neurology, 2014.
31. Wilke SA, Raam T, Antonios JK, Bushong EA, Koo EH, Ellisman MH, Ghosh A. Specific disruption of hippocampal mossy fiber synapses in a mouse model of familial Alzheimer's disease.. PloS one, 2014.
32. Wilke SA, Antonios JK, Bushong EA, Badkoobehi A, Malek E, Hwang M, Terada M, Ellisman MH, Ghosh A. Deconstructing complexity: serial block-face electron microscopic analysis of the hippocampal mossy fiber synapse.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013.
33. Wilke SA, Hall BJ, Antonios JK, Denardo LA, Otto S, Yuan B, Chen F, Robbins EM, Tiglio K, Williams ME, Qiu Z, Biederer T, Ghosh A. NeuroD2 regulates the development of hippocampal mossy fiber synapses.. Neural development, 2012.
34. Williams ME, Wilke SA, Daggett A, Davis E, Otto S, Ravi D, Ripley B, Bushong EA, Ellisman MH, Klein G, Ghosh A. Cadherin-9 regulates synapse-specific differentiation in the developing hippocampus.. Neuron, 2011.
35. Scobie KN, Hall BJ, Wilke SA, Klemenhagen KC, Fujii-Kuriyama Y, Ghosh A, Hen R, Sahay A. Krüppel-like factor 9 is necessary for late-phase neuronal maturation in the developing dentate gyrus and during adult hippocampal neurogenesis.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009.
36. Sopher BL, Thomas PS, LaFevre-Bernt MA, Holm IE, Wilke SA, Ware CB, Jin LW, Libby RT, Ellerby LM, La Spada AR. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration.. Neuron, 2004.